These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 23380218

  • 21. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
    Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Proprionate Clinical Research Study Group.
    J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
    [Abstract] [Full Text] [Related]

  • 22. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A.
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [Abstract] [Full Text] [Related]

  • 23. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
    Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, Bowers B, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930
    [Abstract] [Full Text] [Related]

  • 24. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 25. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
    Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil K.
    J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
    [Abstract] [Full Text] [Related]

  • 26. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 27. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [Abstract] [Full Text] [Related]

  • 28. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L, Potvin E, Korn D, Lachman A, Dramaix M, Gusman J, Peché R, Singulair as Complementary Therapy to Fixed Association in Real life Study Group.
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [Abstract] [Full Text] [Related]

  • 29. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.
    Camargo CA, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, Malice MP, Legrand C, Dass SB, Knorr BA, Reiss TF.
    J Allergy Clin Immunol; 2010 Feb; 125(2):374-80. PubMed ID: 20159247
    [Abstract] [Full Text] [Related]

  • 30. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
    Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF.
    Ann Intern Med; 1999 Mar 16; 130(6):487-95. PubMed ID: 10075616
    [Abstract] [Full Text] [Related]

  • 31. Adherence to asthma controller medication regimens.
    Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
    Respir Med; 2005 Oct 16; 99(10):1263-7. PubMed ID: 16140227
    [Abstract] [Full Text] [Related]

  • 32. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
    van Adelsberg J, Moy J, Wei LX, Tozzi CA, Knorr B, Reiss TF.
    Curr Med Res Opin; 2005 Jun 16; 21(6):971-9. PubMed ID: 15969897
    [Abstract] [Full Text] [Related]

  • 33. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov 16; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

  • 34. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
    Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA, Faris MA, Philpot EE.
    Ann Allergy Asthma Immunol; 2006 Jun 16; 96(6):851-7. PubMed ID: 16802774
    [Abstract] [Full Text] [Related]

  • 35. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
    Nathan RA, Yancey SW, Waitkus-Edwards K, Prillaman BA, Stauffer JL, Philpot E, Dorinsky PM, Nelson HS.
    Chest; 2005 Oct 16; 128(4):1910-20. PubMed ID: 16236835
    [Abstract] [Full Text] [Related]

  • 36. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2007 Jan 16; 119(1):64-72. PubMed ID: 17140647
    [Abstract] [Full Text] [Related]

  • 37. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
    Galant SP, Lawrence M, Meltzer EO, Tomasko M, Baker KA, Kellerman DJ.
    Ann Allergy Asthma Immunol; 1996 Aug 16; 77(2):112-8. PubMed ID: 8760776
    [Abstract] [Full Text] [Related]

  • 38. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years.
    Nelson KA, Smith SR, Trinkaus K, Jaffe DM.
    Pediatr Emerg Care; 2008 Jan 16; 24(1):21-7. PubMed ID: 18165796
    [Abstract] [Full Text] [Related]

  • 39. Effects of mometasone, fluticasone, and montelukast on bone mineral density in adults with asthma.
    Maspero J, Backer V, Yao R, Staudinger H, Teper A.
    J Allergy Clin Immunol Pract; 2013 Jan 16; 1(6):649-55.e1. PubMed ID: 24565713
    [Abstract] [Full Text] [Related]

  • 40. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis.
    Esteitie R, deTineo M, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2010 Aug 16; 105(2):155-61. PubMed ID: 20674827
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.